Ignite Creation Date:
2024-05-06 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05023655
Status:
RECRUITING
Last Update Posted:
2023-04-18
First Post:
2021-08-12
Brief Title:
Phase II Study of Tazemetostat in Solid Tumors Harboring an ARID1A Mutation
Sponsor:
Prisma Health-Upstate
Organization:
Prisma Health-Upstate
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-12
First Submit QC Date:
August 20 2021
Study First Post Date:
2021-08-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-18
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL